NEW YORK (GenomeWeb) – In the two years since it launched proprietary software solutions for next-generation sequence data analysis, GenomOncology has expanded its platform to include a number of additional applications that cater to a much broader range of analysis and interpretation needs.

In this webinar, Dr. Wendy Béguelin of Weill Cornell Medicine will discuss how she used the BD Rhapsody single-cell RNA-seq platform and YFP floxed reporter mouse models to study how lymphoma-associated mutations disrupt the immune system by affecting GC B-cell states, explaining the biology of initiation of low-grade follicular lymphoma.